Outcomes from a medical trial of greater than 250 members with progressive a number of sclerosis (MS) revealed that ibudilast was higher than a placebo in slowing down mind shrinkage. The research additionally confirmed that the principle uncomfortable side effects of ibudilast have been gastrointestinal and complications.